Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets

B Wang, L Wu, J Chen, L Dong, C Chen… - Signal transduction and …, 2021 - nature.com
The arachidonic acid (AA) pathway plays a key role in cardiovascular biology,
carcinogenesis, and many inflammatory diseases, such as asthma, arthritis, etc. Esterified …

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing

JA Johnson, L Gong, M Whirl‐Carrillo… - Clinical …, 2011 - Wiley Online Library
Warfarin is a widely used anticoagulant with a narrow therapeutic index and large
interpatient variability in the dose required to achieve target anticoagulation. Common …

Applications of CYP450 testing in the clinical setting

CF Samer, KI Lorenzini, V Rollason, Y Daali… - Molecular diagnosis & …, 2013 - Springer
Interindividual variability in drug response is a major clinical problem. Polymedication and
genetic polymorphisms modulating drug-metabolising enzyme activities (cytochromes P450 …

Ibuprofen: pharmacology, efficacy and safety

KD Rainsford - Inflammopharmacology, 2009 - Springer
Objectives This review attempts to bring together information from a large number of recent
studies on the clinical uses, safety and pharmacological properties of ibuprofen. Ibuprofen is …

Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects

M Ingelman-Sundberg, SC Sim, A Gomez… - Pharmacology & …, 2007 - Elsevier
The polymorphic nature of the cytochrome P450 (CYP) genes affects individual drug
response and adverse reactions to a great extent. This variation includes copy number …

Drug metabolism and variability among patients in drug response

GR Wilkinson - New England Journal of Medicine, 2005 - Mass Medical Soc
Differences in drug responsiveness are common, often leading to challenges in optimizing
the dosage regimen for a particular patient. Recent advances provide a rational framework …

Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation

UM Zanger, M Turpeinen, K Klein… - Analytical and bioanalytical …, 2008 - Springer
We investigated the elimination routes for the 200 drugs that are sold most often by
prescription count in the United States. The majority (78%) of the hepatically cleared drugs …

Cytochrome P450 in pharmacogenetics: an update

A Tornio, JT Backman - Advances in pharmacology, 2018 - Elsevier
Interindividual variability in drug disposition is a major cause of lack of efficacy and adverse
effects of drug therapies. The majority of hepatically cleared drugs are metabolized by …

Cytochrome P450 pharmacogenetics and cancer

C Rodriguez-Antona, M Ingelman-Sundberg - Oncogene, 2006 - nature.com
The cytochromes P450 (CYPs) are key enzymes in cancer formation and cancer treatment.
They mediate the metabolic activation of numerous precarcinogens and participate in the …

Nonsteroidal antiinflammatory drug resistance in dysmenorrhea: epidemiology, causes, and treatment

FA Oladosu, FF Tu, KM Hellman - American journal of obstetrics and …, 2018 - Elsevier
Although nonsteroidal antiinflammatory drugs can alleviate menstrual pain, about 18% of
women with dysmenorrhea are unresponsive, leaving them and their physicians to pursue …